Literature DB >> 25540141

NOD-like receptors: versatile cytosolic sentinels.

Vinicius Motta1, Fraser Soares1, Tian Sun1, Dana J Philpott1.   

Abstract

Nucleotide binding oligomerization domain (NOD)-like receptors are cytoplasmic pattern-recognition receptors that together with RIG-I-like receptor (retinoic acid-inducible gene 1), Toll-like receptor (TLR), and C-type lectin families make up the innate pathogen pattern recognition system. There are 22 members of NLRs in humans, 34 in mice, and even a larger number in some invertebrates like sea urchins, which contain more than 200 receptors. Although initially described to respond to intracellular pathogens, NLRs have been shown to play important roles in distinct biological processes ranging from regulation of antigen presentation, sensing metabolic changes in the cell, modulation of inflammation, embryo development, cell death, and differentiation of the adaptive immune response. The diversity among NLR receptors is derived from ligand specificity conferred by the leucine-rich repeats and an NH2-terminal effector domain that triggers the activation of different biological pathways. Here, we describe NLR genes associated with different biological processes and the molecular mechanisms underlying their function. Furthermore, we discuss mutations in NLR genes that have been associated with human diseases.
Copyright © 2015 the American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25540141     DOI: 10.1152/physrev.00009.2014

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  93 in total

1.  Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy.

Authors:  Colin Kietzman; Elaine Tuomanen
Journal:  ACS Infect Dis       Date:  2019-07-03       Impact factor: 5.084

2.  Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity.

Authors:  Wenqian Dong; Huafeng Zhang; Xiaonan Yin; Yuying Liu; Degao Chen; Xiaoyu Liang; Xun Jin; Jiadi Lv; Jingwei Ma; Ke Tang; Zhuowei Hu; Xiaofeng Qin; Bo Huang
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

3.  NLR members in inflammation-associated carcinogenesis.

Authors:  Ha Zhu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2017-04-03       Impact factor: 11.530

4.  NLRC3 expression in dendritic cells attenuates CD4+ T cell response and autoimmunity.

Authors:  Yuling Fu; Xiaoxia Zhan; Yichong Wang; Xiaobing Jiang; Min Liu; Yalong Yang; Yulan Huang; Xialin Du; Xiao-Ping Zhong; Laisheng Li; Li Ma; Shengfeng Hu
Journal:  EMBO J       Date:  2019-07-10       Impact factor: 11.598

Review 5.  Strategies for designing synthetic immune agonists.

Authors:  Tom Y-H Wu
Journal:  Immunology       Date:  2016-07-11       Impact factor: 7.397

Review 6.  Epithelial Toll-like receptors and their role in gut homeostasis and disease.

Authors:  Juan F Burgueño; Maria T Abreu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-26       Impact factor: 46.802

7.  The Type II Secretion System of Legionella pneumophila Dampens the MyD88 and Toll-Like Receptor 2 Signaling Pathway in Infected Human Macrophages.

Authors:  Celeste A Mallama; Kessler McCoy-Simandle; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

Review 8.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

9.  For Whom the Bell Tolls (and Nods): Spit-acular Saliva.

Authors:  Dana K Shaw; Michail Kotsyfakis; Joao H F Pedra
Journal:  Curr Trop Med Rep       Date:  2016-04-05

10.  Effects of folic acid withdrawal on transcriptomic profiles in murine triple-negative breast cancer cell lines.

Authors:  Dieuwertje E Kok; Ciara H O'Flanagan; Michael F Coleman; Zahra Ashkavand; Stephen D Hursting; Sergey A Krupenko
Journal:  Biochimie       Date:  2020-04-15       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.